Pre-Clinical Equipment & Supplies In Alberta

The Environics Series Reduced Oxygen Breathing Device 2 is the next generation system that simulates altitude exposure and can be utilized for both research and hypoxia ...

Bertin Bioreagent offers primary and secondary antibodies for laboratories. As essential tools, they are particularly versatile when properly ...

The Environics Series Reduced Oxygen Breathing Device 3 is the newest in our line of systems that simulate altitude exposure and can be utilized for both research and hypoxia training. It is customizable for expanded research ...

Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...

The world’s most efficient AI platform for rare disease drug discovery, supporting our teams and partners in our mission to advance new treatments towards the ...

Sentry is able to identify within seconds whether the tissue being investigated is cancerous or not. Our technology allows surgeons to safely and precisely remove more cancer than current imaging modalities – ultimately leading to better outcomes for ...

Interferons are a group of antiviral proteins produced in reaction to viral infections. It boosts the resistance of surrounding cells to attacks by viruses, inhibits viral multiplication and modifies the body’s immune response. Interferon alfa is the type that has been found to be most useful in the treatment of certain forms of cancer, including metastatic renal cell carcinoma and hairy ...

Tyrosine Kinase Inhibitor of EGFR exon 20 insertion mutations. Non-Small Cell Lung Cancer (Phase 1/2) PHASE ...

The Global Leader in the Discovery of Natural Product Chemistry for Healthcare. Sirenas prides itself on being at the forefront of computational metabolomics for chemical discovery. Our deep experience and historical productivity indicate that these cutting-edge tools, when applied to living systems, can generate the insights necessary to forge new classes of therapeutics and health products. ...

GPEx cell line development technology is a proven technology that generates high-performance, highly stable, production cell lines. Virtually any cDNA (mAb and multigenic applications) can be inserted into cells. To date, over 600 different mAb and mAb fusions and over 160+ different recombinant proteins have been produced using the GPEx system, with 160+ clinical trials utilizing therapeutic ...

Different Platforms for Your Individual Needs.Recognizing that each surgeon’s preferences and the anatomy of each patient’s sinuses are not identical, Hemostasis has developed multiple platforms of our PosiSep® hemostat sinus splints to meet those varying needs. ...

AuroVist-15 nm: Highest contrast of any blood pool contrast agent; Longest blood residence of any x-ray contrast agent. An independent comparison study of microCT contrast agents evaluated AuroVist 15 nm against eXIA160XL, ExiTron nano 12000 and an equivalent iodine-based contrast agent. Their conclusion: "AuroVist 15 nm provided the highest attenuation...AuroVist 15 nm is best suited for ...

Amikacin Cyclops™ is an amikacin dry powder inhaler for the treatment of tuberculosis (TB). Inhaled amikacin from the Cyclops™ will result in higher amikacin concentrations in the lungs than conventional infusion or intramuscular injection. This could more rapidly decrease contagiousness by sterilizing the upper airways of patients with ’open’ (smear positive) TB, ...

The American Lung Association describes acute respiratory distress syndrome (ARDS) as a life-threatening lung injury that allows fluid to leak into the lungs. Breathing becomes difficult and oxygen cannot get into the body. Most people who get ARDS are already at the hospital for trauma or illness. Lung injuries can occur from trauma, an overwhelming immune response due to an infection, allergic ...

DC vaccine derived from patient’s own blood cells is the personalized immunotherapeutic vaccine for cancer and auto-immune diseases. Disease specific antigens-loaded dendritic cell allows the immune cells to recognize and attack only cancer cells through a tumor specific antigen recognition ...

Developed and characterized by a team of dedicated scientists and clinicians, Bria-IMT™ (SV-BR-1-GM) is a targeted immunotherapy being developed for the treatment of advanced breast cancer (i.e. breast cancer that has spread from the breast or armpit to other areas of the body including the bones, lungs, liver or sometimes the brain). Bria-IMT™ is a genetically engineered human breast ...

Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and long-lasting immune responses in vaccinated subjects and can therefore protect people ...

Bria-IMT™ (developed from a breast cancer cell line) is a patented (USPTO) immunotherapy approach that directly stimulates the body’s own cancer fighting cells to attack and destroy breast cancer tumors. ...

BrainsWay’s treatment was cleared by the FDA in 2013 for patients who tried any number of antidepressants with no improvement in the current depressive episode. The FDA indication is based on a unique 16-week double-blind, placebo-controlled, multi-center study which enrolled over 200 subjects, and reported a marked decline in HDRS-21 scores, as well as significant remission (32.6%) and ...

IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar ...